OncLive

Talquetamab Plus Daratumumab Earns CHMP Backing in R/R Myeloma

October 16, 2026

The source didn’t give us enough text to summarize this story. Use “Read original source” above to read it at OncLive.

Want more like this?

Browse more from the feed. A free account unlocks the full feed, saving and communities.